AOD-9604 Fat Loss Protocol
C-terminal hGH fragment (176-191). Stimulates lipolysis and inhibits lipogenesis without affecting IGF-1.
Aug 27, 2026
1 min
C-terminal hGH fragment (176-191). Stimulates lipolysis and inhibits lipogenesis without affecting IGF-1.
FDA-approved GHRH analogue selectively reducing visceral adipose tissue. Approved for HIV lipodystrophy.
Mitochondrial-derived peptide regulating glucose metabolism and insulin sensitivity via AMPK activation.
AOD-9604 + Tesamorelin + MOTS-c + 5-Amino-1MQ targeting visceral fat, insulin resistance, and mitochondrial efficiency.